Both in Pharmaceuticals
Mentari Therapeutics vs Savara
| Metric | MTRI | SVRA |
|---|---|---|
| Price | $18.35 | $4.72 |
| Market cap | $1.07B | $1.04B |
| Today | +17.56% | −5.41% |
| 1 month | — | −0.8% |
| 6 months | — | −10.4% |
| Year to date | — | −21.7% |
| 1 year | — | +9.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $99.4M |
| Dividend yield | — | — |
| Volatility (60d) | — | 52.8% |
| Short % of float | 0.2% | 22.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).